Synapse - Steven Horwitz

Search Within

Steven M Horwitz

Results (671)

Diffuse large B-cell lymphoma version 1.2016

Journal Article

Zelenetz, A. D.; Gordon, L. I.; Wierda, W. G.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Byrd, J. C.; Fayad, L. E.; Fisher, R. I.; more...
Journal of the National Comprehensive Cancer Network (2016)

Fulltext@MSK | Save

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): Final results from the T-cell consortium trial

Journal Article

Advani, R. H.; Ansell, S. M.; Lechowicz, M. J.; Beaven, A. W.; Loberiza, F.; Carson, K. R.; Evens, A. M.; Foss, F.; Horwitz, S.; Pro, B.; more...
British Journal of Haematology (2016)

Fulltext@MSK | Save

Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma

Journal Article

Clemens, M. W.; Medeiros, L. J.; Butler, C. E.; Hunt, K. K.; Fanale, M. A.; Horwitz, S.; Weisenburger, D. D.; Liu, J.; Morgan, E. A.; Kanagal-Shamanna, R.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Central nervous system involvement in T-cell lymphoma: A single center experience

Meeting Abstract

Mehta, N.; Gurion, R.; Maragulia, J.; Zelenetz, A.; Moskowitz, A.; Moskowitz, C.; Hamlin, P.; Horwitz, S.
Clinical Lymphoma, Myeloma and Leukemia (2015)

Fulltext@MSK | Save

Refractory T-cell prolymphocytic leukemia with JAK3 mutation: In vitro and clinical synergy of tofacitinib and ruxolitinib

Meeting Abstract

Wei, M.; Koshy, N.; van Besien, K.; Inghirami, G.; Horwitz, S. M.
Blood (2015)

Fulltext@MSK | Save

Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma

Meeting Abstract

Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Younes, A.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; more...
Blood (2015)

Fulltext@MSK | Save

Successful treatment of peripheral T-cell lymphoma with allogeneic stem cell transplantation: A large single-center experience

Meeting Abstract

Mehta-Shah, N.; Chou, J.; Maloy, M.; Zhang, Z. G.; Moskowitz, A. J.; Moskowitz, C. H.; Barker, J. N.; Giralt, S.; Perales, M. A.; Horwitz, S. M.; more...
Blood (2015)

Fulltext@MSK | Save

Results from a phase 1/2, open-label, dose-finding study of pralatrexate and oral bexarotene in patients with relapsed/refractory cutaneous T-cell lymphoma

Meeting Abstract

Duvic, M.; Horwitz, S. M.; Kim, Y. H.; Zinzani, P. L.; Bhat, G.; Sharma, P.; Yancik, S.
Blood (2015)

Fulltext@MSK | Save

Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay

Meeting Abstract

Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
Blood (2015)

Fulltext@MSK | Save

Frontline treatment of CD30+peripheral T-cell lymphomas with brentuximab vedotin in combination with CHP: 3-year durability and survival follow-up

Meeting Abstract

Horwitz, S. M.; Shustov, A. R.; Forero-Torres, A.; Bartlett, N. L.; Advani, R.; Pro, B.; Chen, R.; Davies, A. J.; Illidge, T.; Huebner, D.; more...
Blood (2015)

Fulltext@MSK | Save